| The relationship between circulating testosterone and inflammatory cytokines in men |
32 |
| The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes |
21 |
| Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction |
14 |
| Trends in cardiovascular diseases and associated risks in sub-Saharan Africa: a review of the evidence for Ghana, Nigeria, South Africa, Sudan and Tanzania |
11 |
| Association between serum levels of testosterone and biomarkers of subclinical atherosclerosis |
8 |
| Influence of testosterone substitution on glycemic control and endothelial markers in men with newly diagnosed functional hypogonadism and type 2 diabetes mellitus: a randomized controlled trial |
8 |
| Interleukin-18 and testosterone levels in men with metabolic syndrome |
8 |
| Reference database of hematological parameters for growing and aging rats |
8 |
| Testosterone, testosterone therapy and prostate cancer |
7 |
| Impact of metabolic status on the association of serum vitamin D with hypogonadism and lower urinary tract symptoms/benign prostatic hyperplasia |
7 |
| The use of selective estrogen receptor modulators on bone health in men |
7 |
| Determination of oxidative stress levels and some antioxidant enzyme activities in prostate cancer |
6 |
| Clinical and metabolic implications of obesity in prostate cancer: is testosterone a missing link? |
6 |
| Research of stroke combined hyperlipidemia-induced erectile dysfunction in rat model |
6 |
| Sleep disturbance as a clinical sign for severe hypogonadism: efficacy of testosterone replacement therapy on sleep disturbance among hypogonadal men without obstructive sleep apnea |
6 |
| The relationship between vitamin D level and erectile dysfunction in patients with type 2 diabetes mellitus |
5 |
| Complete blood count parameters in peripheral arterial disease |
5 |
| Administration of daily 5mg tadalafil improves endothelial function in patients with benign prostatic hyperplasia |
5 |
| Adherence to Mediterranean diet and risk of prostate cancer |
5 |
| Analysis of cardiovascular risk factors associated with serum testosterone levels according to the US 2011-2012 National Health and Nutrition Examination Survey |
4 |
| PI3K pathway and Bcl-2 family. Clinicopathological features in prostate cancer |
4 |
| Prevalence analysis of urinary incontinence after radical prostatectomy and influential preoperative factors in a single institution |
4 |
| Evaluation of quality of life in patients undergoing surgery for benign prostatic hyperplasia |
4 |
| Cognitive functions and health-related quality of life in men with benign prostatic hyperplasia and symptoms of overactive bladder when treated with a combination of tamsulosin and solifenacin in a higher dosage |
3 |
| Folate: a possible role in erectile dysfunction? |
3 |
| Association between hand-grip strength and erectile dysfunction in older men |
3 |
| Should information about sexual health be included in education directed toward men with cardiovascular diseases? |
3 |
| Bioactive compounds of the Mediterranean diet and prostate cancer |
3 |
| Treatment of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction |
3 |
| Effects of resistance training on liver structure and function of aged rats |
3 |
| The influence of nutritional factors on prostate cancer incidence and aggressiveness |
3 |
| Transurethral resection of the prostate achieves favorable outcomes in stroke patients with symptomatic benign prostate hyperplasia |
3 |
| Aging male symptomatology and eating behavior |
3 |
| Association of vitamin D status and the risk of cardiovascular disease as assessed by various cardiovascular risk scoring systems in patients with type 2 diabetes mellitus |
3 |
| Effect of cigarette smoking on sexual functions, psychological factors, and disease activity in male patients with ankylosing spondylitis |
3 |
| Physical exercise, nutrition and hormones: three pillars to fight sarcopenia |
3 |
| The prevalence and severity of varicocele in adult population over the age of forty years old: a cross-sectional study |
3 |
| Total training load may explain similar strength gains and muscle hypertrophy seen in aged rats submitted to resistance training and anabolic steroids |
3 |
| Efficacy of newer medications for lower urinary tract symptoms attributed to benign prostatic hyperplasia: a systematic review |
2 |
| Association between sarcopenia and erectile dysfunction in males with type II diabetes mellitus |
2 |
| No association of serum PSA with vitamin D or total oxidant-antioxidant capacity in healthy men |
2 |
| Concurrent training protocol for men with androgen deficiency in the aging male: a randomized clinical trial |
2 |
| Comparison of the effectiveness of IPSS and VPSS without any help in LUTS patients: a prospective study |
2 |
| Increased visceral adiposity index associated with sexual dysfunction in men |
2 |
| A nationwide cohort study of the role of CHADS(2) score in predicting lower extremity amputation and death among patients with peripheral arterial occlusive disease |
2 |
| Cystatin C as a predictor of mortality in elderly patients with chronic kidney disease |
2 |
| Testosterone level in aging male with different glucose tolerance state and its association with osteocalcin |
2 |
| The association between hypogonadism symptoms with serum testosterone, FSH and LH in men |
2 |
| Radical prostatectomy for clinically localized prostate cancer in patients aged 75 years or older: comparison with primary androgen deprivation therapy |
2 |
| Association between dietary phytoestrogens intakes and prostate cancer risk in Sicily |
2 |
